Quantum Genomics
Pre-clinicalDevelops novel therapies targeting the brain aminopeptidase A pathway for hypertension and heart failure.
Founded
2007
Focus
Small Molecules
About
Develops novel therapies targeting the brain aminopeptidase A pathway for hypertension and heart failure.
Funding History
3Total raised: $55M
IPO$20MUndisclosedMar 23, 2017
Series B$25MUndisclosedJun 15, 2015
Series A$10MUndisclosedJun 15, 2013
Company Info
TypePrivate
Founded2007
LocationParis, France
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile